Home/Filings/4/0001209191-22-035286
4//SEC Filing

Callori Fred 4

Accession 0001209191-22-035286

CIK 0001785345other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 8:54 AM ET

Size

5.2 KB

Accession

0001209191-22-035286

Insider Transaction Report

Form 4
Period: 2022-06-07
Callori Fred
Director
Transactions
  • Award

    Stock Option (right to buy)

    2022-06-07+18,00018,000 total
    Exercise: $0.91Exp: 2032-06-06Common Stock (18,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option will vest and become exercisable on June 7, 2023, subject to the Reporting Person providing continuous service through such date.

Issuer

Landos Biopharma, Inc.

CIK 0001785345

Entity typeother

Related Parties

1
  • filerCIK 0001843393

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 8:54 AM ET
Size
5.2 KB